Data di Pubblicazione:
2016
Citazione:
Effects of rituximab in connective tissue disorders related interstitial lung disease / Lepri, G., Avouac, J., Airò, P., Anguita Santos, F., BELLANDO RANDONE, S., Blagojevic, J., Garcia Hernàndez, F., Gonzalez Nieto, J.A., Guiducci, S., Jordan, S., Limaye, V., Maurer, B., Selva O'Callaghan, A., Riccieri, V., Distler, O., MATUCCI CERINIC, M., Allanore, Y.. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 34 Suppl 100:(2016), pp. 181-185.
Abstract:
Interstitial lung disease (ILD) is a key prognostic factor in connective tissue disorders (CTDs). The aim of our study was to assess the changes in pulmonary functional tests (PFTs) in various CTDs, including anti-synthetase syndrome (SYN), systemic sclerosis (SSc) and mixed connective tissue disorder (MCTD), following the use of rituximab therapy.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Systemic Sclerosis; rituximab
Elenco autori:
Lepri, Gemma; Avouac, Jerome; Airò, Paolo; Anguita Santos, Francisco; BELLANDO RANDONE, Silvia; Blagojevic, Jelena; Garcia Hernàndez, Francisco; Gonzalez Nieto, Jose Antonio; Guiducci, Serena; Jordan, Suzana; Limaye, Vidya; Maurer, Britta; Selva O'Callaghan, Albert; Riccieri, Valeria; Distler, Oliver; MATUCCI CERINIC, Marco; Allanore, Yannick
Link alla scheda completa:
Pubblicato in: